Literature DB >> 2789821

The prevalence of cancer in Sweden 1984.

H O Adami1, T Gunnarsson, P Sparén, G Eklund.   

Abstract

A total of 772,492 (99.3%) of all patients with a newly diagnosed malignant disease notified to the National Swedish Cancer Registry during 1958 through 1984 could be followed up with respect to survival or emigration by means of computerized record linkages. The number of cancer patients still alive on December 31, 1984, totalling 194,389, was divided by the appropriate population denominator. The crude prevalence rate in Sweden of individuals who have or have had any cancer was 1,840 per 10(5) in males and 2,808 per 10(5) in females. At ages 40 through 59, the rates in females were 2.2 to 2.5 times higher than those in males, whereas after the age of 75 cancer was more prevalent in males. Prostate cancer was the most common tumour in males, 24.5% of the crude prevalence rate (451 per 10(5), followed by colorectal cancer, cancer of the bladder and malignant melanoma. In females, the breast was the dominating cancer site, accounting for 32.7% (917 per 10(5), followed by cancer of the large bowel, uterine corpus and uterine cervix. We conclude that prevalence rates provide important information about the magnitude of the cancer problem over and above that revealed by incidence and mortality statistics. The high, and probably increasing, prevalence rates over time emphasize that important savings in economic and other resources can be achieved by strictly evaluated and cost-effective regimens for follow-up.

Entities:  

Mesh:

Year:  1989        PMID: 2789821     DOI: 10.3109/02841868909092251

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

Review 1.  The risk of large bowel cancer after partial gastrectomy for benign ulcer disease.

Authors:  G Lundegårdh; H O Adami; C Helmick; M Zack
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

2.  Breast cancer incidence and prevalence estimated from survival and mortality.

Authors:  R Capocaccia; A Verdecchia; A Micheli; M Sant; G Gatta; F Berrino
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

3.  Risk-adjusted cancer-incidence rates (United States).

Authors:  R M Merrill; E J Feuer
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

4.  Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.

Authors:  J Yuen; I Persson; L Bergkvist; R Hoover; C Schairer; H O Adami
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

5.  Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology.

Authors:  Kimberly R Porter; Bridget J McCarthy; Sally Freels; Yoonsang Kim; Faith G Davis
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

6.  [Prevalence of cancer in the Guadalajara health area].

Authors:  J M Alonso Gordo; A Bárcena Marugán; D Jiménez Del Val; J J Palacios Rojo; C Royo Sánchez; J Urbina Torija
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

7.  Condylomata acuminata and risk of cancer: an epidemiological study.

Authors:  B Sigurgeirsson; B Lindelöf; G Eklund
Journal:  BMJ       Date:  1991-08-10

Review 8.  The role of cancer registries in cancer control.

Authors:  Donald Maxwell Parkin
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

9.  Mortality due to primary brain tumours in China and detection rate in people with suspected symptoms: a nationally representative cross-sectional survey.

Authors:  Bin Jiang; Hongmei Liu; Dongling Sun; Haixin Sun; Xiaojuan Ru; Jie Fu; Siqi Ge; Wenzhi Wang
Journal:  World J Surg Oncol       Date:  2021-03-12       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.